Patient-Directed Antimicrobial Duration in Acute Uncomplicated Pyelonephritis

Completed · Phase 4 · Has a placebo group

Conditions studied: Pyelonephritis Acute

In brief

This pilot study will randomize 40 female patients with acute uncomplicated pyelonephritis to receive standard duration of therapy versus patient-directed antimicrobial duration (PDAD). The primary objectives of this pilot trial are to determine the feasibility and safety of conducting a full-scale multi-center randomized controlled trial.

Key facts

Study ID

NCT06127160

Run by

Brett A Faine

People needed

39

Starts

2024-06-04

Expected to finish

2025-08-29

Last updated by the study team

2026-08-03

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: accepted.

Where it is running

• Olive View - UCLA Medical Center — Sylmar, California, United States
• University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.